nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—hematologic cancer—muscle cancer	0.903	1	CtDrD
Bexarotene—Purpura—Doxorubicin—muscle cancer	0.000134	0.00139	CcSEcCtD
Bexarotene—Abdominal pain—Dactinomycin—muscle cancer	0.000134	0.00139	CcSEcCtD
Bexarotene—Body temperature increased—Dactinomycin—muscle cancer	0.000134	0.00139	CcSEcCtD
Bexarotene—Loss of consciousness—Etoposide—muscle cancer	0.000132	0.00137	CcSEcCtD
Bexarotene—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000132	0.00137	CcSEcCtD
Bexarotene—Lethargy—Doxorubicin—muscle cancer	0.000132	0.00137	CcSEcCtD
Bexarotene—Decreased appetite—Vincristine—muscle cancer	0.000132	0.00136	CcSEcCtD
Bexarotene—Cough—Etoposide—muscle cancer	0.000131	0.00136	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Vincristine—muscle cancer	0.000131	0.00136	CcSEcCtD
Bexarotene—Fatigue—Vincristine—muscle cancer	0.000131	0.00135	CcSEcCtD
Bexarotene—Hyponatraemia—Doxorubicin—muscle cancer	0.00013	0.00135	CcSEcCtD
Bexarotene—Hypertension—Etoposide—muscle cancer	0.00013	0.00135	CcSEcCtD
Bexarotene—Pain—Vincristine—muscle cancer	0.00013	0.00134	CcSEcCtD
Bexarotene—Constipation—Vincristine—muscle cancer	0.00013	0.00134	CcSEcCtD
Bexarotene—Osteoarthritis—Doxorubicin—muscle cancer	0.00013	0.00134	CcSEcCtD
Bexarotene—RXRA—renal system—muscle cancer	0.000128	0.148	CbGeAlD
Bexarotene—Chest pain—Etoposide—muscle cancer	0.000128	0.00133	CcSEcCtD
Bexarotene—Eosinophilia—Methotrexate—muscle cancer	0.000128	0.00133	CcSEcCtD
Bexarotene—Migraine—Doxorubicin—muscle cancer	0.000128	0.00132	CcSEcCtD
Bexarotene—Affect lability—Doxorubicin—muscle cancer	0.000128	0.00132	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000127	0.00132	CcSEcCtD
Bexarotene—Pancreatitis—Methotrexate—muscle cancer	0.000127	0.00131	CcSEcCtD
Bexarotene—Discomfort—Etoposide—muscle cancer	0.000127	0.00131	CcSEcCtD
Bexarotene—Face oedema—Doxorubicin—muscle cancer	0.000125	0.0013	CcSEcCtD
Bexarotene—Hypersensitivity—Dactinomycin—muscle cancer	0.000125	0.00129	CcSEcCtD
Bexarotene—Gastrointestinal pain—Vincristine—muscle cancer	0.000124	0.00128	CcSEcCtD
Bexarotene—Confusional state—Etoposide—muscle cancer	0.000124	0.00128	CcSEcCtD
Bexarotene—Pancytopenia—Methotrexate—muscle cancer	0.000123	0.00127	CcSEcCtD
Bexarotene—Mood swings—Doxorubicin—muscle cancer	0.000123	0.00127	CcSEcCtD
Bexarotene—Infection—Etoposide—muscle cancer	0.000122	0.00126	CcSEcCtD
Bexarotene—Ataxia—Doxorubicin—muscle cancer	0.000122	0.00126	CcSEcCtD
Bexarotene—Asthenia—Dactinomycin—muscle cancer	0.000122	0.00126	CcSEcCtD
Bexarotene—Blood creatinine increased—Doxorubicin—muscle cancer	0.000121	0.00126	CcSEcCtD
Bexarotene—Neutropenia—Methotrexate—muscle cancer	0.000121	0.00125	CcSEcCtD
Bexarotene—Dysuria—Methotrexate—muscle cancer	0.000121	0.00125	CcSEcCtD
Bexarotene—Dehydration—Doxorubicin—muscle cancer	0.00012	0.00125	CcSEcCtD
Bexarotene—Thrombocytopenia—Etoposide—muscle cancer	0.00012	0.00125	CcSEcCtD
Bexarotene—Tachycardia—Etoposide—muscle cancer	0.00012	0.00124	CcSEcCtD
Bexarotene—Abdominal pain—Vincristine—muscle cancer	0.00012	0.00124	CcSEcCtD
Bexarotene—Body temperature increased—Vincristine—muscle cancer	0.00012	0.00124	CcSEcCtD
Bexarotene—Liver function test abnormal—Doxorubicin—muscle cancer	0.00012	0.00124	CcSEcCtD
Bexarotene—Skin disorder—Etoposide—muscle cancer	0.000119	0.00124	CcSEcCtD
Bexarotene—Erectile dysfunction—Methotrexate—muscle cancer	0.000119	0.00123	CcSEcCtD
Bexarotene—Dry skin—Doxorubicin—muscle cancer	0.000119	0.00123	CcSEcCtD
Bexarotene—Hyperhidrosis—Etoposide—muscle cancer	0.000119	0.00123	CcSEcCtD
Bexarotene—Photosensitivity reaction—Methotrexate—muscle cancer	0.000118	0.00122	CcSEcCtD
Bexarotene—Hypokalaemia—Doxorubicin—muscle cancer	0.000118	0.00122	CcSEcCtD
Bexarotene—Anorexia—Etoposide—muscle cancer	0.000117	0.00121	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000117	0.00121	CcSEcCtD
Bexarotene—Diarrhoea—Dactinomycin—muscle cancer	0.000116	0.0012	CcSEcCtD
Bexarotene—Pneumonia—Methotrexate—muscle cancer	0.000116	0.0012	CcSEcCtD
Bexarotene—Muscular weakness—Doxorubicin—muscle cancer	0.000114	0.00118	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000114	0.00118	CcSEcCtD
Bexarotene—Abdominal distension—Doxorubicin—muscle cancer	0.000113	0.00117	CcSEcCtD
Bexarotene—Stomatitis—Methotrexate—muscle cancer	0.000112	0.00116	CcSEcCtD
Bexarotene—Conjunctivitis—Methotrexate—muscle cancer	0.000112	0.00116	CcSEcCtD
Bexarotene—Influenza—Doxorubicin—muscle cancer	0.000112	0.00116	CcSEcCtD
Bexarotene—Dysphagia—Doxorubicin—muscle cancer	0.000112	0.00116	CcSEcCtD
Bexarotene—Hypersensitivity—Vincristine—muscle cancer	0.000112	0.00116	CcSEcCtD
Bexarotene—Eosinophilia—Doxorubicin—muscle cancer	0.000111	0.00115	CcSEcCtD
Bexarotene—Sweating—Methotrexate—muscle cancer	0.000111	0.00115	CcSEcCtD
Bexarotene—Paraesthesia—Etoposide—muscle cancer	0.00011	0.00114	CcSEcCtD
Bexarotene—Haematuria—Methotrexate—muscle cancer	0.00011	0.00114	CcSEcCtD
Bexarotene—Pancreatitis—Doxorubicin—muscle cancer	0.00011	0.00114	CcSEcCtD
Bexarotene—Dyspnoea—Etoposide—muscle cancer	0.000109	0.00113	CcSEcCtD
Bexarotene—Somnolence—Etoposide—muscle cancer	0.000109	0.00113	CcSEcCtD
Bexarotene—Angina pectoris—Doxorubicin—muscle cancer	0.000109	0.00113	CcSEcCtD
Bexarotene—Epistaxis—Methotrexate—muscle cancer	0.000109	0.00113	CcSEcCtD
Bexarotene—Asthenia—Vincristine—muscle cancer	0.000109	0.00113	CcSEcCtD
Bexarotene—Vomiting—Dactinomycin—muscle cancer	0.000108	0.00112	CcSEcCtD
Bexarotene—Bronchitis—Doxorubicin—muscle cancer	0.000108	0.00112	CcSEcCtD
Bexarotene—Rash—Dactinomycin—muscle cancer	0.000107	0.00111	CcSEcCtD
Bexarotene—Decreased appetite—Etoposide—muscle cancer	0.000107	0.00111	CcSEcCtD
Bexarotene—Pancytopenia—Doxorubicin—muscle cancer	0.000106	0.0011	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Etoposide—muscle cancer	0.000106	0.0011	CcSEcCtD
Bexarotene—Fatigue—Etoposide—muscle cancer	0.000106	0.0011	CcSEcCtD
Bexarotene—Constipation—Etoposide—muscle cancer	0.000105	0.00109	CcSEcCtD
Bexarotene—Pain—Etoposide—muscle cancer	0.000105	0.00109	CcSEcCtD
Bexarotene—Dysuria—Doxorubicin—muscle cancer	0.000105	0.00108	CcSEcCtD
Bexarotene—Neutropenia—Doxorubicin—muscle cancer	0.000105	0.00108	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—muscle cancer	0.000104	0.00108	CcSEcCtD
Bexarotene—Diarrhoea—Vincristine—muscle cancer	0.000104	0.00107	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—muscle cancer	0.000104	0.00107	CcSEcCtD
Bexarotene—Pollakiuria—Doxorubicin—muscle cancer	0.000103	0.00107	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—muscle cancer	0.000103	0.00106	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—muscle cancer	0.000102	0.00106	CcSEcCtD
Bexarotene—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000102	0.00106	CcSEcCtD
Bexarotene—Weight increased—Doxorubicin—muscle cancer	0.000102	0.00106	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—muscle cancer	0.000101	0.00105	CcSEcCtD
Bexarotene—Weight decreased—Doxorubicin—muscle cancer	0.000101	0.00105	CcSEcCtD
Bexarotene—Feeling abnormal—Etoposide—muscle cancer	0.000101	0.00105	CcSEcCtD
Bexarotene—Hyperglycaemia—Doxorubicin—muscle cancer	0.000101	0.00105	CcSEcCtD
Bexarotene—Nausea—Dactinomycin—muscle cancer	0.000101	0.00104	CcSEcCtD
Bexarotene—Pneumonia—Doxorubicin—muscle cancer	0.0001	0.00104	CcSEcCtD
Bexarotene—Gastrointestinal pain—Etoposide—muscle cancer	0.0001	0.00104	CcSEcCtD
Bexarotene—Dizziness—Vincristine—muscle cancer	0.0001	0.00104	CcSEcCtD
Bexarotene—Neuropathy peripheral—Doxorubicin—muscle cancer	9.79e-05	0.00101	CcSEcCtD
Bexarotene—Jaundice—Doxorubicin—muscle cancer	9.73e-05	0.00101	CcSEcCtD
Bexarotene—Stomatitis—Doxorubicin—muscle cancer	9.73e-05	0.00101	CcSEcCtD
Bexarotene—Abdominal pain—Etoposide—muscle cancer	9.71e-05	0.00101	CcSEcCtD
Bexarotene—Body temperature increased—Etoposide—muscle cancer	9.71e-05	0.00101	CcSEcCtD
Bexarotene—Urinary tract infection—Doxorubicin—muscle cancer	9.71e-05	0.00101	CcSEcCtD
Bexarotene—Conjunctivitis—Doxorubicin—muscle cancer	9.71e-05	0.00101	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—muscle cancer	9.67e-05	0.001	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—muscle cancer	9.65e-05	0.001	CcSEcCtD
Bexarotene—Vomiting—Vincristine—muscle cancer	9.64e-05	0.000998	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—muscle cancer	9.61e-05	0.000995	CcSEcCtD
Bexarotene—Sweating—Doxorubicin—muscle cancer	9.57e-05	0.000992	CcSEcCtD
Bexarotene—Rash—Vincristine—muscle cancer	9.56e-05	0.00099	CcSEcCtD
Bexarotene—Dermatitis—Vincristine—muscle cancer	9.55e-05	0.000989	CcSEcCtD
Bexarotene—Haematuria—Doxorubicin—muscle cancer	9.52e-05	0.000986	CcSEcCtD
Bexarotene—Headache—Vincristine—muscle cancer	9.5e-05	0.000984	CcSEcCtD
Bexarotene—RXRB—cardiac atrium—muscle cancer	9.47e-05	0.109	CbGeAlD
Bexarotene—Epistaxis—Doxorubicin—muscle cancer	9.42e-05	0.000976	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—muscle cancer	9.39e-05	0.000973	CcSEcCtD
Bexarotene—Sinusitis—Doxorubicin—muscle cancer	9.37e-05	0.00097	CcSEcCtD
Bexarotene—Chills—Methotrexate—muscle cancer	9.29e-05	0.000962	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—muscle cancer	9.15e-05	0.000948	CcSEcCtD
Bexarotene—Hypersensitivity—Etoposide—muscle cancer	9.05e-05	0.000937	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—muscle cancer	9.01e-05	0.000934	CcSEcCtD
Bexarotene—Erythema—Methotrexate—muscle cancer	9.01e-05	0.000934	CcSEcCtD
Bexarotene—Haemoglobin—Doxorubicin—muscle cancer	9.01e-05	0.000933	CcSEcCtD
Bexarotene—Nausea—Vincristine—muscle cancer	9e-05	0.000933	CcSEcCtD
Bexarotene—Rhinitis—Doxorubicin—muscle cancer	8.99e-05	0.000931	CcSEcCtD
Bexarotene—Haemorrhage—Doxorubicin—muscle cancer	8.96e-05	0.000929	CcSEcCtD
Bexarotene—Hypoaesthesia—Doxorubicin—muscle cancer	8.92e-05	0.000924	CcSEcCtD
Bexarotene—Pharyngitis—Doxorubicin—muscle cancer	8.9e-05	0.000922	CcSEcCtD
Bexarotene—Urinary tract disorder—Doxorubicin—muscle cancer	8.85e-05	0.000917	CcSEcCtD
Bexarotene—Oedema peripheral—Doxorubicin—muscle cancer	8.83e-05	0.000915	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—muscle cancer	8.82e-05	0.000914	CcSEcCtD
Bexarotene—Asthenia—Etoposide—muscle cancer	8.81e-05	0.000913	CcSEcCtD
Bexarotene—Connective tissue disorder—Doxorubicin—muscle cancer	8.81e-05	0.000912	CcSEcCtD
Bexarotene—Urethral disorder—Doxorubicin—muscle cancer	8.79e-05	0.00091	CcSEcCtD
Bexarotene—RXRG—tendon—muscle cancer	8.78e-05	0.101	CbGeAlD
Bexarotene—Back pain—Methotrexate—muscle cancer	8.72e-05	0.000903	CcSEcCtD
Bexarotene—Pruritus—Etoposide—muscle cancer	8.69e-05	0.0009	CcSEcCtD
Bexarotene—RXRA—head—muscle cancer	8.57e-05	0.099	CbGeAlD
Bexarotene—Diarrhoea—Etoposide—muscle cancer	8.4e-05	0.00087	CcSEcCtD
Bexarotene—Eye disorder—Doxorubicin—muscle cancer	8.38e-05	0.000868	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—muscle cancer	8.36e-05	0.000866	CcSEcCtD
Bexarotene—Tinnitus—Doxorubicin—muscle cancer	8.36e-05	0.000866	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—muscle cancer	8.33e-05	0.000863	CcSEcCtD
Bexarotene—Cardiac disorder—Doxorubicin—muscle cancer	8.32e-05	0.000862	CcSEcCtD
Bexarotene—RXRB—tendon—muscle cancer	8.25e-05	0.0953	CbGeAlD
Bexarotene—Angiopathy—Doxorubicin—muscle cancer	8.13e-05	0.000842	CcSEcCtD
Bexarotene—Malaise—Methotrexate—muscle cancer	8.13e-05	0.000842	CcSEcCtD
Bexarotene—Dizziness—Etoposide—muscle cancer	8.12e-05	0.000841	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—muscle cancer	8.1e-05	0.000839	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—muscle cancer	8.07e-05	0.000836	CcSEcCtD
Bexarotene—Chills—Doxorubicin—muscle cancer	8.04e-05	0.000833	CcSEcCtD
Bexarotene—Arrhythmia—Doxorubicin—muscle cancer	8.01e-05	0.00083	CcSEcCtD
Bexarotene—Alopecia—Doxorubicin—muscle cancer	7.92e-05	0.000821	CcSEcCtD
Bexarotene—Cough—Methotrexate—muscle cancer	7.86e-05	0.000815	CcSEcCtD
Bexarotene—Vomiting—Etoposide—muscle cancer	7.81e-05	0.000809	CcSEcCtD
Bexarotene—Erythema—Doxorubicin—muscle cancer	7.8e-05	0.000808	CcSEcCtD
Bexarotene—Malnutrition—Doxorubicin—muscle cancer	7.8e-05	0.000808	CcSEcCtD
Bexarotene—Rash—Etoposide—muscle cancer	7.74e-05	0.000802	CcSEcCtD
Bexarotene—Dermatitis—Etoposide—muscle cancer	7.73e-05	0.000801	CcSEcCtD
Bexarotene—Headache—Etoposide—muscle cancer	7.69e-05	0.000797	CcSEcCtD
Bexarotene—Flatulence—Doxorubicin—muscle cancer	7.69e-05	0.000797	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—muscle cancer	7.67e-05	0.000795	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—muscle cancer	7.67e-05	0.000795	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—muscle cancer	7.67e-05	0.000795	CcSEcCtD
Bexarotene—RXRB—vagina—muscle cancer	7.66e-05	0.0884	CbGeAlD
Bexarotene—Tension—Doxorubicin—muscle cancer	7.66e-05	0.000793	CcSEcCtD
Bexarotene—Dysgeusia—Doxorubicin—muscle cancer	7.64e-05	0.000792	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	7.62e-05	0.000789	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—muscle cancer	7.58e-05	0.000785	CcSEcCtD
Bexarotene—Nervousness—Doxorubicin—muscle cancer	7.58e-05	0.000785	CcSEcCtD
Bexarotene—Back pain—Doxorubicin—muscle cancer	7.55e-05	0.000782	CcSEcCtD
Bexarotene—RXRG—head—muscle cancer	7.52e-05	0.0869	CbGeAlD
Bexarotene—Muscle spasms—Doxorubicin—muscle cancer	7.5e-05	0.000777	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—muscle cancer	7.42e-05	0.000768	CcSEcCtD
Bexarotene—Infection—Methotrexate—muscle cancer	7.31e-05	0.000757	CcSEcCtD
Bexarotene—Nausea—Etoposide—muscle cancer	7.29e-05	0.000756	CcSEcCtD
Bexarotene—RXRG—testis—muscle cancer	7.27e-05	0.0839	CbGeAlD
Bexarotene—Ill-defined disorder—Doxorubicin—muscle cancer	7.24e-05	0.00075	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—muscle cancer	7.21e-05	0.000747	CcSEcCtD
Bexarotene—Anaemia—Doxorubicin—muscle cancer	7.21e-05	0.000747	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—muscle cancer	7.2e-05	0.000746	CcSEcCtD
Bexarotene—Agitation—Doxorubicin—muscle cancer	7.17e-05	0.000743	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—muscle cancer	7.14e-05	0.00074	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—muscle cancer	7.11e-05	0.000737	CcSEcCtD
Bexarotene—RXRB—head—muscle cancer	7.07e-05	0.0817	CbGeAlD
Bexarotene—Malaise—Doxorubicin—muscle cancer	7.04e-05	0.000729	CcSEcCtD
Bexarotene—Vertigo—Doxorubicin—muscle cancer	7.01e-05	0.000726	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—muscle cancer	7.01e-05	0.000726	CcSEcCtD
Bexarotene—Syncope—Doxorubicin—muscle cancer	7e-05	0.000725	CcSEcCtD
Bexarotene—Leukopenia—Doxorubicin—muscle cancer	6.98e-05	0.000724	CcSEcCtD
Bexarotene—Palpitations—Doxorubicin—muscle cancer	6.9e-05	0.000714	CcSEcCtD
Bexarotene—Loss of consciousness—Doxorubicin—muscle cancer	6.86e-05	0.00071	CcSEcCtD
Bexarotene—RXRB—testis—muscle cancer	6.83e-05	0.0789	CbGeAlD
Bexarotene—Cough—Doxorubicin—muscle cancer	6.81e-05	0.000705	CcSEcCtD
Bexarotene—Hypertension—Doxorubicin—muscle cancer	6.74e-05	0.000698	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—muscle cancer	6.7e-05	0.000694	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—muscle cancer	6.65e-05	0.000689	CcSEcCtD
Bexarotene—Myalgia—Doxorubicin—muscle cancer	6.64e-05	0.000688	CcSEcCtD
Bexarotene—Arthralgia—Doxorubicin—muscle cancer	6.64e-05	0.000688	CcSEcCtD
Bexarotene—Chest pain—Doxorubicin—muscle cancer	6.64e-05	0.000688	CcSEcCtD
Bexarotene—Anxiety—Doxorubicin—muscle cancer	6.62e-05	0.000686	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—muscle cancer	6.6e-05	0.000684	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	6.6e-05	0.000683	CcSEcCtD
Bexarotene—Discomfort—Doxorubicin—muscle cancer	6.56e-05	0.00068	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—muscle cancer	6.56e-05	0.000679	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—muscle cancer	6.54e-05	0.000677	CcSEcCtD
Bexarotene—Dry mouth—Doxorubicin—muscle cancer	6.5e-05	0.000673	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—muscle cancer	6.47e-05	0.000671	CcSEcCtD
Bexarotene—Confusional state—Doxorubicin—muscle cancer	6.42e-05	0.000665	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—muscle cancer	6.39e-05	0.000662	CcSEcCtD
Bexarotene—Oedema—Doxorubicin—muscle cancer	6.37e-05	0.00066	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—muscle cancer	6.35e-05	0.000658	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—muscle cancer	6.34e-05	0.000657	CcSEcCtD
Bexarotene—Infection—Doxorubicin—muscle cancer	6.33e-05	0.000655	CcSEcCtD
Bexarotene—Pain—Methotrexate—muscle cancer	6.29e-05	0.000652	CcSEcCtD
Bexarotene—Shock—Doxorubicin—muscle cancer	6.27e-05	0.000649	CcSEcCtD
Bexarotene—Nervous system disorder—Doxorubicin—muscle cancer	6.24e-05	0.000647	CcSEcCtD
Bexarotene—Thrombocytopenia—Doxorubicin—muscle cancer	6.23e-05	0.000646	CcSEcCtD
Bexarotene—Tachycardia—Doxorubicin—muscle cancer	6.22e-05	0.000644	CcSEcCtD
Bexarotene—Skin disorder—Doxorubicin—muscle cancer	6.19e-05	0.000641	CcSEcCtD
Bexarotene—Hyperhidrosis—Doxorubicin—muscle cancer	6.16e-05	0.000638	CcSEcCtD
Bexarotene—Anorexia—Doxorubicin—muscle cancer	6.07e-05	0.000629	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—muscle cancer	6.06e-05	0.000628	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—muscle cancer	6.01e-05	0.000623	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—muscle cancer	5.81e-05	0.000602	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—muscle cancer	5.81e-05	0.000602	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Doxorubicin—muscle cancer	5.8e-05	0.000601	CcSEcCtD
Bexarotene—Insomnia—Doxorubicin—muscle cancer	5.76e-05	0.000597	CcSEcCtD
Bexarotene—Paraesthesia—Doxorubicin—muscle cancer	5.72e-05	0.000592	CcSEcCtD
Bexarotene—Dyspnoea—Doxorubicin—muscle cancer	5.68e-05	0.000588	CcSEcCtD
Bexarotene—Somnolence—Doxorubicin—muscle cancer	5.66e-05	0.000586	CcSEcCtD
Bexarotene—Dyspepsia—Doxorubicin—muscle cancer	5.61e-05	0.000581	CcSEcCtD
Bexarotene—Decreased appetite—Doxorubicin—muscle cancer	5.54e-05	0.000573	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Doxorubicin—muscle cancer	5.5e-05	0.00057	CcSEcCtD
Bexarotene—Fatigue—Doxorubicin—muscle cancer	5.49e-05	0.000569	CcSEcCtD
Bexarotene—Constipation—Doxorubicin—muscle cancer	5.45e-05	0.000564	CcSEcCtD
Bexarotene—Pain—Doxorubicin—muscle cancer	5.45e-05	0.000564	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—muscle cancer	5.42e-05	0.000561	CcSEcCtD
Bexarotene—Asthenia—Methotrexate—muscle cancer	5.28e-05	0.000547	CcSEcCtD
Bexarotene—Feeling abnormal—Doxorubicin—muscle cancer	5.25e-05	0.000544	CcSEcCtD
Bexarotene—Gastrointestinal pain—Doxorubicin—muscle cancer	5.21e-05	0.000539	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—muscle cancer	5.2e-05	0.000539	CcSEcCtD
Bexarotene—Abdominal pain—Doxorubicin—muscle cancer	5.03e-05	0.000522	CcSEcCtD
Bexarotene—Body temperature increased—Doxorubicin—muscle cancer	5.03e-05	0.000522	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—muscle cancer	5.03e-05	0.000521	CcSEcCtD
Bexarotene—Dizziness—Methotrexate—muscle cancer	4.86e-05	0.000504	CcSEcCtD
Bexarotene—Hypersensitivity—Doxorubicin—muscle cancer	4.69e-05	0.000486	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—muscle cancer	4.68e-05	0.000484	CcSEcCtD
Bexarotene—Rash—Methotrexate—muscle cancer	4.64e-05	0.00048	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—muscle cancer	4.63e-05	0.00048	CcSEcCtD
Bexarotene—Headache—Methotrexate—muscle cancer	4.61e-05	0.000477	CcSEcCtD
Bexarotene—Asthenia—Doxorubicin—muscle cancer	4.57e-05	0.000473	CcSEcCtD
Bexarotene—Pruritus—Doxorubicin—muscle cancer	4.51e-05	0.000467	CcSEcCtD
Bexarotene—Nausea—Methotrexate—muscle cancer	4.37e-05	0.000453	CcSEcCtD
Bexarotene—Diarrhoea—Doxorubicin—muscle cancer	4.36e-05	0.000451	CcSEcCtD
Bexarotene—Dizziness—Doxorubicin—muscle cancer	4.21e-05	0.000436	CcSEcCtD
Bexarotene—Vomiting—Doxorubicin—muscle cancer	4.05e-05	0.000419	CcSEcCtD
Bexarotene—Rash—Doxorubicin—muscle cancer	4.02e-05	0.000416	CcSEcCtD
Bexarotene—Dermatitis—Doxorubicin—muscle cancer	4.01e-05	0.000416	CcSEcCtD
Bexarotene—Headache—Doxorubicin—muscle cancer	3.99e-05	0.000413	CcSEcCtD
Bexarotene—Nausea—Doxorubicin—muscle cancer	3.78e-05	0.000392	CcSEcCtD
Bexarotene—CYP3A4—renal system—muscle cancer	2.37e-05	0.0273	CbGeAlD
